BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 755231)

  • 21. [Studies on the usefulness of the copper-Folin method of Lowry in the quantitative estimation of albumin in cerebrospinal fluid].
    Diessner H; Knore W
    Nervenarzt; 1968 Mar; 39(3):135-7. PubMed ID: 5646995
    [No Abstract]   [Full Text] [Related]  

  • 22. [Polyacrylamide gel electrophoresis of the cerebrospinal fluid proteins. Attempt at classification].
    Seneterre JB; Grimaud D; Quincy C; Pegon Y
    Ann Biol Clin (Paris); 1974; 32(6):521-7. PubMed ID: 4468744
    [No Abstract]   [Full Text] [Related]  

  • 23. [Quantitative immunochemistry of cerebrospinal fluid proteins in inflammatory diseases of the nervous system].
    Gottesleben A; Bauer HJ
    Ger Med Mon; 1967 Jul; 12(7):331-4. PubMed ID: 4169059
    [No Abstract]   [Full Text] [Related]  

  • 24. [The importance of the Takata-Ara reaction in spinal fluid examinations].
    Hanzal F; Hovorková B
    Cesk Neurol; 1967 Mar; 30(2):118-23. PubMed ID: 4167141
    [No Abstract]   [Full Text] [Related]  

  • 25. [Composition of cerebrospinal fluid protein in children with nervous system diseases according to disc-electrophoresis in polyacrylamide gel].
    Nesterovskiĭ EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(6):869-72. PubMed ID: 952152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ratios of CSF protein fractions and their use in laboratory diagnosis (author's transl)].
    Rieder HP; Fritschi J
    Nervenarzt; 1980; 51(12):704-7. PubMed ID: 7207680
    [No Abstract]   [Full Text] [Related]  

  • 27. [Nervous system diseases and proteins in the blood and cerebrospinal fluid].
    Ito H; Miura S
    Saishin Igaku; 1968 Aug; 23(8):1651-61. PubMed ID: 4883043
    [No Abstract]   [Full Text] [Related]  

  • 28. [Methods of protein gradient determination for diagnostic use in the clinical laboratory].
    Schulz D; Rothenhöfer C
    Fortschr Med; 1982 Feb; 100(8):303-6. PubMed ID: 7084874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid proteomics - work in progress.
    Avasarala JR
    Eur J Neurol; 2008 Sep; 15(9):891-2. PubMed ID: 18796074
    [No Abstract]   [Full Text] [Related]  

  • 30. [The pattern of cerebrospinal fluid proteins in infants and children. Determination of normal values (author's transl)].
    Gerbaut L; Ponsot G; Dulac O; Olive G; Arthuis M
    Arch Fr Pediatr; 1981 Jan; 38(1):3-9. PubMed ID: 7224799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunoelectrophoresis of cerebrospinal fluid proteins].
    Merelli E; Previdi P
    Riv Neurobiol; 1977; 23(4):229-33. PubMed ID: 617891
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cerebro-spinal fluid (CSF) protein fractions and immunoglobulins in various neurological diseases].
    Ninomiya T
    Nihon Ika Daigaku Zasshi; 1983 Jun; 50(3):420-6. PubMed ID: 6885976
    [No Abstract]   [Full Text] [Related]  

  • 33. Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry.
    Stoop MP; Dekker LJ; Titulaer MK; Burgers PC; Sillevis Smitt PA; Luider TM; Hintzen RQ
    Proteomics; 2008 Apr; 8(8):1576-85. PubMed ID: 18351689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-albumin (GFA) dosage and localization in human nervous tissue and cerebrospinal fluid.
    Noppe M; Lowenthal A; Gheuens J; Karcher D
    Cell Mol Biol Incl Cyto Enzymol; 1979; 25(6):415-20. PubMed ID: 540287
    [No Abstract]   [Full Text] [Related]  

  • 35. Free and bound N-acetyl neuraminic acid in the cerebrospinal fluid in various neurological disorders.
    Balasubramanian AS; Raman PT; Taori GM
    Indian J Med Res; 1974 May; 62(5):781-7. PubMed ID: 4435890
    [No Abstract]   [Full Text] [Related]  

  • 36. Beta-trace protein concentration in CSF in neurological disorders.
    Link H; Olsson JE
    Acta Neurol Scand; 1972; 48(1):57-68. PubMed ID: 4623111
    [No Abstract]   [Full Text] [Related]  

  • 37. Analysis of cerebrospinal fluid from patients with psychiatric and neurological disorders by two-dimensional electrophoresis: identification of disease-associated polypeptides as fibrin fragments.
    Wildenauer DB; Körschenhausen D; Hoechtlen W; Ackenheil M; Kehl M; Lottspeich F
    Electrophoresis; 1991; 12(7-8):487-92. PubMed ID: 1915241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly sensitive analysis of gangliosides in human cerebrospinal fluid with neurological diseases.
    Yamanaka T; Hirabayashi Y; Koketsu K; Higashi H; Matsumoto M
    Jpn J Exp Med; 1987 Apr; 57(2):131-5. PubMed ID: 3312728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thromboplastic activity of cerebrospinal fluid in neurological disease.
    Tutuarima JA; Hische EA; van Trotsenburg L; van der Helm HJ
    Clin Chem; 1985 Jan; 31(1):99-100. PubMed ID: 3965223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoelectrophoresis of cerebrospinal fluid in neurological disorders.
    Masih EB; Hussain QZ; Mehrotra AN
    J Assoc Physicians India; 1970 May; 18(5):515-20. PubMed ID: 5474274
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.